Start
Amniotics
About us
Corporate Governance
General Meeting
Nomination Committee
Board of Directors
Management
Auditors
Articles of association
Donors
R&D
Pipeline
Diseases
Stem Cell Therapies
Publications
HyperTargIPS-NK
Participants
News
CDMO services
Partnering
Investors
Financial Reports
Företrädesemission Q4 2023
Preferential Rights Issue Q1 2023
IPO 2021
Financial calendar
Key financials
Share information
Events
Analyst coverage
IR contacts
Magle Chemoswed bid
Merger
Media
All Press & News
Press Releases
News
Media gallery
Career
Open positions
Menu
Menu
Start
Amniotics
▼
About us
Corporate Governance
▼
General Meeting
Nomination Committee
Board of Directors
Management
Auditors
Articles of association
Donors
R&D
▼
Pipeline
Diseases
Stem Cell Therapies
Publications
HyperTargIPS-NK
▼
Participants
News
CDMO services
Partnering
Investors
▲
Financial Reports
Företrädesemission Q4 2023
Preferential Rights Issue Q1 2023
IPO 2021
Financial calendar
Key financials
Share information
Events
Analyst coverage
IR contacts
Magle Chemoswed bid
Merger
Media
▼
All Press & News
Press Releases
News
Media gallery
Career
▼
Open positions
Investors
Investors
Financial Reports
Företrädesemission Q4 2023
Preferential Rights Issue Q1 2023
IPO 2021
Financial calendar
Key financials
Share information
Events
Analyst coverage
IR contacts
Magle Chemoswed bid
Merger
Financial Reports
2024
Amniotics AB (publ) Rapport över det första halvåret 2024
2023
Amniotics årsredovisning 2023 publicerad
Amniotics AB (publ) Report for the fourth quarter 2023.
Amniotics AB (publ) Rapport över det Fjärde Kvartalet 2023
Amniotics AB (publ) Rapport över det Tredje Kvartalet 2023
Amniotics AB (publ) Report for the third Quarter 2023
Amniotics AB (publ) Report for the second Quarter 2023
Amniotics AB (publ) Rapport över det Andra Kvartalet 2023
Amniotics AB (publ) Rapport över det Första Kvartalet 2023
Amniotics AB (publ) Report for the First Quarter 2023
2022
Amniotics årsredovisning 2022 publicerad
Amniotics publicerar rapport för fjärde kvartalet 2022
Amniotics AB Report for the Fourth Quarter 2022
Amniotics publicerar rapport för tredje kvartalet 2022
Amniotics publishes its report for the third quarter of 2022
Rapport över det andra kvartalet 2022
Report for the Second Quarter 2022
Rapport över det första kvartalet 2022
Interim Report, 1st Quarter 2022
2021
Amniotics publishes 2021 Annual report
Amniotics årsredovisning 2021 publicerad
Rapport över det fjärde kvartalet 2021
Report for the Fourth Quarter 2021
Rapport över det tredje kvartalet 2021
Interim Report, 3rd Quarter 2021
Interim Report, 2nd Quarter 2021
Interim Report, 1st Quarter 2021
Interim Report, 1st Quarter 2021
(.pdf, Swedish)
2020
Annual report 2020
(.pdf, Swedish)
2019
Annual report 2019
(.pdf, Swedish)
Upcoming events
Read more
Subscribe